Clinical Trials Search Tool

A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

Disease/Condition: Migraine Headache

Location: Portland

Ages: 18+

Enrollment Opens: 07/21/2021

Enrollment Closes: TBD


This is a study for patients with CHRONIC migraine and patients must have between 4-18 migraine attacks per month and 6 or more migraine days per month. The study is looking at the safety and effectiveness of oral Zavegepant in the prevention of chronic migraine attacks.

Study ID: Biohaven 3500-302

To Enroll: Please call (503) 228-2273 (CARE) to talk with someone about setting up an intake appointment. Or contact for additional informaton.

Posted by: Summit Headlands LLC |